Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,238 | 228 | 83.5% |
| Travel and Lodging | $1,141 | 3 | 15.3% |
| Education | $89.99 | 1 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PROCEPT BioRobotics Corporation | $1,010 | 5 | $0 (2024) |
| Astellas Pharma US Inc | $859.02 | 50 | $0 (2024) |
| Teleflex LLC | $828.55 | 5 | $0 (2024) |
| Axonics, Inc. | $687.00 | 25 | $0 (2024) |
| BOSTON SCIENTIFIC CORPORATION | $421.79 | 10 | $0 (2021) |
| Dendreon Pharmaceuticals LLC | $359.54 | 8 | $0 (2019) |
| ABBVIE INC. | $292.47 | 17 | $0 (2024) |
| UROGEN PHARMA, INC. | $221.99 | 2 | $0 (2024) |
| Janssen Biotech, Inc. | $214.47 | 7 | $0 (2024) |
| HealthTronics Mobile Solutions, LLC | $209.65 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,382 | 63 | PROCEPT BioRobotics Corporation ($1,010) |
| 2023 | $429.17 | 13 | Axonics, Inc. ($360.87) |
| 2022 | $254.18 | 13 | Antares Pharma, Inc. ($38.41) |
| 2021 | $499.63 | 19 | Olympus America Inc. ($150.00) |
| 2020 | $314.86 | 15 | Astellas Pharma US Inc ($168.21) |
| 2019 | $733.33 | 41 | Astellas Pharma US Inc ($138.32) |
| 2018 | $1,048 | 33 | BOSTON SCIENTIFIC CORPORATION ($298.72) |
| 2017 | $808.38 | 35 | Astellas Pharma US Inc ($237.70) |
All Payment Transactions
232 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Agiliti Surgical, Inc. | Koelis Trinity Fusion Biopsy System (Device) | Food and Beverage | Cash or cash equivalent | $60.24 | General |
| Category: Surgical Lasers | ||||||
| 12/17/2024 | Tolmar, Inc. | JATENZO (Drug), ELIGARD | Food and Beverage | Cash or cash equivalent | $18.00 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 12/16/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $5.66 | General |
| Category: Urology | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $113.14 | General |
| Category: Oncology | ||||||
| 12/11/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: Oncology | ||||||
| 12/09/2024 | 180 Medical, Inc. | GENTLECATH (Device) | Food and Beverage | In-kind items and services | $27.52 | General |
| Category: CONTINENCE CARE | ||||||
| 11/20/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: UROLOGY | ||||||
| 11/19/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $25.38 | General |
| Category: Diagnostic Imaging | ||||||
| 11/05/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: HORMONE THERAPY | ||||||
| 10/24/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $104.06 | General |
| Category: UROTHELIAL CANCER | ||||||
| 10/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $25.77 | General |
| Category: Oncology | ||||||
| 10/08/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: HORMONE THERAPY | ||||||
| 10/07/2024 | 180 Medical, Inc. | GENTLECATH (Device) | Food and Beverage | In-kind items and services | $26.76 | General |
| Category: CONTINENCE CARE | ||||||
| 10/03/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Oncology | ||||||
| 10/01/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: UROLOGY | ||||||
| 09/30/2024 | Tolmar, Inc. | ELIGARD (Drug) | Food and Beverage | Cash or cash equivalent | $14.54 | General |
| Category: ONCOLOGY | ||||||
| 09/24/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $26.79 | General |
| Category: UROLOGY | ||||||
| 09/10/2024 | ConvaTec Inc. | GENTLECATH GLIDE (Device) | Food and Beverage | In-kind items and services | $27.10 | General |
| Category: CONTINENCE CARE | ||||||
| 09/10/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: HORMONE THERAPY | ||||||
| 09/10/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: Oncology | ||||||
| 09/04/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $106.80 | General |
| Category: UROLOGY | ||||||
| 09/04/2024 | 180 Medical, Inc. | GENTLECATH (Device) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: CONTINENCE CARE | ||||||
| 09/03/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Travel and Lodging | Cash or cash equivalent | $551.96 | General |
| Category: UROLOGY | ||||||
| 09/03/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Travel and Lodging | Cash or cash equivalent | $296.86 | General |
| Category: UROLOGY | ||||||
| 08/24/2024 | Teleflex LLC | — | Food and Beverage | Cash or cash equivalent | $194.99 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 2,519 | 3,126 | $394,654 | $161,417 |
| 2022 | 27 | 2,121 | 2,677 | $390,237 | $169,914 |
| 2021 | 26 | 1,472 | 2,245 | $320,308 | $148,107 |
| 2020 | 30 | 1,438 | 1,854 | $274,198 | $98,433 |
All Medicare Procedures & Services
110 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3490 | Unclassified drugs | Office | 2023 | 31 | 89 | $65,320 | $41,356 | 63.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 352 | 431 | $94,389 | $38,105 | 40.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 462 | 588 | $88,200 | $33,909 | 38.4% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 67 | 75 | $35,175 | $11,957 | 34.0% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 14 | 15 | $14,669 | $5,074 | 34.6% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 226 | 266 | $13,566 | $4,793 | 35.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 34 | 34 | $11,356 | $3,878 | 34.1% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 19 | 19 | $9,690 | $3,359 | 34.7% |
| 11980 | Placement of hormone pellet under skin | Office | 2023 | 31 | 42 | $9,156 | $3,103 | 33.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 288 | 346 | $3,460 | $2,898 | 83.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 40 | 40 | $8,800 | $2,670 | 30.3% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 196 | 236 | $10,856 | $1,730 | 15.9% |
| 84154 | Psa (prostate specific antigen) measurement, free | Office | 2023 | 86 | 92 | $4,692 | $1,658 | 35.3% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 40 | 48 | $3,408 | $1,214 | 35.6% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 20 | 20 | $7,200 | $919.60 | 12.8% |
| 81003 | Automated urinalysis test | Office | 2023 | 290 | 386 | $2,702 | $849.20 | 31.4% |
| 82670 | Measurement of total estradiol (hormone) | Office | 2023 | 23 | 28 | $2,156 | $766.64 | 35.6% |
| 87086 | Bacterial colony count, urine | Office | 2023 | 77 | 94 | $2,256 | $743.54 | 33.0% |
| 87186 | Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution | Office | 2023 | 42 | 62 | $1,488 | $525.75 | 35.3% |
| 87077 | Bacterial culture for aerobic isolates | Office | 2023 | 43 | 63 | $1,512 | $498.96 | 33.0% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 17 | 17 | $867.00 | $321.64 | 37.1% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2023 | 30 | 33 | $990.00 | $321.03 | 32.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 19 | 20 | $1,080 | $222.20 | 20.6% |
| 87088 | Bacterial urine culture | Office | 2023 | 19 | 24 | $552.00 | $190.31 | 34.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 20 | 22 | $484.00 | $167.42 | 34.6% |
About Dr. Mark Mccurdy, MD
Dr. Mark Mccurdy, MD is a Urology healthcare provider based in Arlington, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1255327383.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Mccurdy, MD has received a total of $7,469 in payments from pharmaceutical and medical device companies, with $3,382 received in 2024. These payments were reported across 232 transactions from 52 companies. The most common payment nature is "Food and Beverage" ($6,238).
As a Medicare-enrolled provider, Mccurdy has provided services to 7,550 Medicare beneficiaries, totaling 9,902 services with total Medicare billing of $577,870. Data is available for 4 years (2020–2023), covering 110 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Arlington, TX
- Active Since 09/23/2005
- Last Updated 11/26/2019
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1255327383
Products in Payments
- AQUABEAM SYSTEM (Device) $1,010
- Axonics (Device) $556.46
- PROVENGE (Drug) $478.50
- MYRBETRIQ (Drug) $275.78
- JELMYTO (Drug) $221.99
- Endocare Cryocare System (Device) $209.65
- XTANDI (Drug) $203.45
- XIAFLEX (Biological) $185.66
- GENERAL BPH (Device) $157.91
- ERLEADA (Drug) $157.55
- iTIND System (Device) $155.36
- INTERSTIM (Device) $144.47
- GENERAL THERAPIES (Device) $140.81
- Myrbetriq (Drug) $140.10
- Xtandi (Drug) $132.61
- Axonics r-SNM System (Device) $126.60
- Erleada (Drug) $115.90
- ORGOVYX (Drug) $107.07
- JEVTANA (Drug) $90.51
- GEMTESA (Drug) $84.58
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Arlington
James Vestal, Md, MD
Urology — Payments: $345,727
Andrew Sun, M.d, M.D
Urology — Payments: $226,377
Harrison Abrahams, Md, MD
Urology — Payments: $188,019
Richard Bevan-Thomas, Md, MD
Urology — Payments: $37,593
Tracy Cannon-Smith, Md, MD
Urology — Payments: $33,795
Dr. Geoffrey Nuss, Md, MD
Urology — Payments: $17,075